|
![]() ![]() ![]() ![]() ![]() ![]()
Vivo Ventures is a life-sciences focused venture capital firm formed in 1996 with over $650M under management. Vivo Ventures is currently making investments from its $275M sixth fund into promising biotechnology and life science companies.
|
Recent News
APT Pharmaceuticals Secures $32 Million in Series B Financing
Sagent Completes $30 Million Series A Financing Extension SpectraGenics Announces $30M in New Funding Changes Company Name to Tria Beauty AVANIR to Raise $40.0 Million to Fund Zenvia Through Clinical Development and Regulatory Approval Carbylan Announces $20 Million Series B Financing Yaupon Therapeutics closes $14.5 million financing -- Series C financing positions company to advance development of its product portfolio targeting cancer and central nervous system diseases |